Strs Ohio Decreases Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Strs Ohio cut its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 12.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,700 shares of the company’s stock after selling 1,100 shares during the period. Strs Ohio’s holdings in Addus HomeCare were worth $714,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Louisiana State Employees Retirement System purchased a new stake in shares of Addus HomeCare in the 4th quarter worth $752,000. Cerity Partners LLC increased its stake in shares of Addus HomeCare by 15.6% in the 4th quarter. Cerity Partners LLC now owns 71,129 shares of the company’s stock worth $6,604,000 after purchasing an additional 9,578 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Addus HomeCare by 3.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 38,197 shares of the company’s stock worth $3,547,000 after purchasing an additional 1,146 shares in the last quarter. Trust Point Inc. purchased a new stake in shares of Addus HomeCare in the 4th quarter worth $517,000. Finally, Legato Capital Management LLC increased its stake in shares of Addus HomeCare by 109.5% in the 4th quarter. Legato Capital Management LLC now owns 13,435 shares of the company’s stock worth $1,247,000 after purchasing an additional 7,021 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ADUS. Oppenheimer restated an “outperform” rating and issued a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. William Blair reiterated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Barclays lowered Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target for the company. in a research note on Tuesday. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. One research analyst has rated the stock with a sell rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $103.00.

Addus HomeCare Trading Down 4.0 %

Shares of ADUS stock opened at $91.70 on Friday. The stock has a fifty day simple moving average of $97.73 and a two-hundred day simple moving average of $91.59. Addus HomeCare Co. has a 52-week low of $77.30 and a 52-week high of $114.97. The firm has a market capitalization of $1.49 billion, a PE ratio of 23.88, a PEG ratio of 1.87 and a beta of 0.96. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, February 26th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The business had revenue of $276.35 million during the quarter, compared to the consensus estimate of $274.02 million. On average, analysts predict that Addus HomeCare Co. will post 4.38 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.